SCHEMBL19386192

SCHEMBL19386192

CC1=C(O)C=CC(F)([N+](=O)[O-])C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29196007 0.68
SCHEMBL28454898 0.67 SMN1; SMN2 (0.33)
SCHEMBL3100514 0.61
SCHEMBL1496507 0.61
SCHEMBL18856537 0.55 ALDH1A1 (0.32)
SCHEMBL7478363 0.55
SCHEMBL365160 0.54
P-Xylene SCHEMBL9492886 0.46 ACHE (0.62)
SCHEMBL272478 0.46 NLRP3 (0.36)
SCHEMBL28996979 0.46 NLRP3 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250009723-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE FIMBRION THERAPEUTICS, INC. 2025-01-09 US disclosed
US-20220235087-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE FIMBRION THERAPEUTICS, INC. 2022-07-28 US disclosed
US-20200407390-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE FIMBRION THERAPEUTICS INC (US) 2020-12-31 US disclosed
US-10738070-B2 Mannose-derived antagonists of FimH useful for treating disease FIMBRION THERAPEUTICS, INC. (US) 2020-08-11 US disclosed
US-20190106451-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE CLIMATE LLC 2019-04-11 US disclosed
EP-3432892-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE Fimbrion Therapeutics, Inc. (US) 2019-01-30 EP disclosed
WO-2017165619-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE FIMBRION THERAPEUTICS, INC. (US) 2017-09-28 WO disclosed